Global Artificial Intelligence (AI) In Biopharmaceuticals Market Forecast to Reach $6.58 Billion by 2029, Driven by 33.0% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Does the Forecast Indicate for the Artificial Intelligence (AI) In Biopharmaceuticals Market From 2025 to 2029?
The market size for artificial intelligence (AI) in biopharmaceuticals has witnessed a rapid expansion in the preceding years. The market is projected to escalate from $1.59 billion in 2024 to $2.1 billion in 2025, representing a compound annual growth rate (CAGR) of 32.2%. This surge in the historical period is contributable to growth strides in computational prowess, an outburst of biomedical data, the paradigm of precision medicine, coupled with regulatory backing and guidance.
The AI in biopharmaceuticals sector is predicted to undergo extensive growth in the coming years, reaching a market size of $6.58 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 33.0%. This potential boost during the projected period is credited to the evolution in computational biology, the fusion of multiple types of data, the intersection of AI with life sciences, regulatory endorsements and structures, and the principles of unbiased and ethical AI. The forecast period will also witness several prime trends such as the incorporation of multi-omics data, AI-powered drug conception and discovery, interpretive AI and regulatory approval, technological progress, regulatory shifts, and budding opportunities.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
What Elements Are Contributing To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
The rise in chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market. Chronic illnesses are persisting conditions that usually advance gradually and can last for a number of years or even a lifetime. They are caused by lifestyle choices, an older demographic, hereditary factors, and environmental influences. AI in biopharmaceuticals is being increasingly utilized for the management of chronic illnesses due its capacity to process vast amounts of varied data sources, spot patterns, and customize treatment plans. For example, the Department of Health and Human Services reported in November 2023 that there was an 11 percent increase in newly reported cases of chronic Hepatitis B in 2022 compared to 2021, demonstrating the escalating prevalence of chronic diseases. This rise in chronic diseases is therefore propelling the growth of the artificial intelligence (AI) in biopharmaceuticals market.
The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
What Future Market Trends Are Projected For The Artificial Intelligence (AI) In Biopharmaceuticals Industry?
Top corporations in the biopharmaceutical AI sector are concentrating their efforts on the creation of groundbreaking advancements like AI-empowered solutions for target and lead identification suites, which can expedite the process of drug discovery and precision medicine, thereby revolutionizing life sciences organizations. These innovative strategies cover a range of methods for creating new drugs and customizing treatments for individual patients. For example, in May 2023, Google LLC, a US-based cloud computing services provider, rolled out two new AI tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding protein structures, a key element in drug development. Furthermore, these suites will enable researchers to consume, store, analyze, and distribute large volumes of genomic data, a vital component in precision medicine. These tools aim to simplify the drug discovery procedures, decrease expenses, and speed up the time it takes to bring new treatments to the marketplace. The tools offer effective data management, precise predictions of protein structures, and sophisticated genomic analysis capabilities, aiming to overhaul the process of drug development and enhance patient outcomes.
Who Are The Key Contributors To Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Which Region Is Projected To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market By 2025?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
